C3 and metabolic dysfunction-associated steatotic liver disease: It was found that in 74% of NAFLD patients, there was deposition of activated forms of C3 and C4 in the liver tissue; in most C3-positive livers, C1q and MBL deposition was also observed, and 50% of activated C3-positive patients presented MAC formation in the liver.